Interferon-γ: an overview of signals, mechanisms and functions
The DOI matches its Crossref record; 433 of the 443 references it cites were found in a registry or an index.
Abstract
Interferon-γ (IFN-γ) coordinates a diverse array of cellular programs through transcriptional regulation of immunologically relevant genes. This article reviews the current understanding of IFN-γ ligand, receptor, ignal transduction, and cellular effects with a focus on macrophage responses and to a lesser extent, responses from other cell types that influence macrophage function during infection. The current model for IFN-γ signal transduction is discussed, as well as signal regulation and factors conferring signal specificity. Cellular effects of IFN-γ are described, including up-regulation of pathogen recognition, antigen processing and presentation, the antiviral state, inhibition of cellular proliferation and effects on apoptosis, activation of microbicidal effector functions, immunomodulation, and leukocyte trafficking. In addition, integration of signaling and response with other cytokines and pathogen-associated molecular patterns, such as tumor necrosis factor-α, interleukin-4, type I IFNs, and lipopolysaccharide are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, the proteins encoded by these genes are all reported to be part of a signaling cascade upstream of interferon regulatory factor 1 (IRF1) and downstream of interferon-γ (IFNγ; ref. 50).”
From scPerturb: harmonized single-cell perturbation data (2024) · cites this paper as [50]
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J., Xie, Q.-W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,211 · cited 3×
“, peroxynitrite) to mediate cytotoxicity by a wide variety of mechanisms [281, 370, 371].”
InfluentialDarnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932 · cited 2×
“, Stat1:Stat1:IRF-9, Stat1:Stat2:IRF-9) form during signaling [102, 116–118].”
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
CELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890 · cited 7×
“Chaperones such as tapasin and GP96 implicated in aiding in the efficient assembly of peptide:MHC I complexes are also up-regulated by IFN- [4, 309, 310].”
InfluentialPeroxynitrite oxidation of sulfhydryls.
Radi, R., Beckman, J. S., Bush, K. M., & Freeman, B. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64313-7 · Cited by 2,490
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453 · cited 2×
“fend against a broad spectrum of pathogens [60, 61].”
Trinchieri, G. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.001343 · Cited by 2,399
Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M., Kapur, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337679100 · Cited by 2,240
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
Xie, Q. W., Kashiwabara, Y., & Nathan, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37600-7 · Cited by 2,212
Radi, R., Beckman, J. S., Bush, K. M., & Freeman, B. A. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90224-7 · Cited by 2,194
CRM1 Is an Export Receptor for Leucine-Rich Nuclear Export Signals
Fornerod, M., Ohno, M., Yoshida, M., & Mattaj, I. W. (1997) · Cell · doi:10.1016/s0092-8674(00)80371-2 · Cited by 2,081 · cited 1×
“Stat1 dephosphorylation by a nuclear protein tyrosine phosphate (PTP) allows the release of DNA and subsequent recognition of the NES by chromosome region maintenance/exportin 1 (CRM1), an export receptor for NES-containing proteins [190, 191].”
Unresponsiveness of MyD88-Deficient Mice to Endotoxin
Kawai, T., Adachi, O., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80086-2 · Cited by 2,076
Structural design and molecular evolution of a cytokine receptor superfamily.
Bazan, J. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6934 · Cited by 2,069 · cited 1×
“It is likely that the IFNGR chains and other family members (type I IFN receptor and tissue factor) evolved from primitive adhesive molecules [33, 34].”
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066 · cited 1×
“One of the most inducible targets of IFN- is a specific feedback inhibitor, SOCS-1, which associates with Jak1/2, interfering with tyrosine kinase activity and inhibiting downstream IFN- signaling [173–177].”
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974 · cited 3×
“platelet-derived growth factor [110–112, 123, 124].”
Interferon-γ and B Cell Stimulatory Factor-1 Reciprocally Regulate Ig Isotype Production
Snapper, C. M., & Paul, W. E. (1987) · Science · doi:10.1126/science.3107127 · Cited by 1,920
Nuclear targeting sequences — a consensus?
Dingwall, C., & Laskey, R. A. (1991) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(91)90184-w · Cited by 1,876 · cited 1×
“[139]) has been identified for Stat1, indicating an as-yet unidentified, novel NLS is unmasked during Stat1 homodimerization, or the NLS of a Stat1 homodimer-binding partner mediates nuclear translocation.”
Pestka, S., Langer, J. A., Zoon, K. C., & Samuel, C. E. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003455 · Cited by 1,825
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808 · cited 1×
“[102–104]).”
IRF Family of Transcription Factors as Regulators of Host Defense
Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658 · cited 1×
“[157]).”
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656 · cited 3×
“This is supported by the Stat1 KO mouse, which displays loss of only IFN signaling, despite multiple reports of Stat1 activation in response to a range of other cytokines in vitro [106, 151].”
Essential role of Stat6 in IL-4 signalling
Takeda, K., Tanaka, T., Shi, W., Matsumoto, M., Minami, M., Kashiwamura, S.-I., Nakanishi, K., Yoshida, N., Kishimoto, T., & Akira, S. (1996) · Nature · doi:10.1038/380627a0 · Cited by 1,557
Immune Response in Mice that Lack the Interferon-γ Receptor
Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilček, J., Zinkernagel, R. M., & Aguet, M. (1993) · Science · doi:10.1126/science.8456301 · Cited by 1,548 · cited 3×
“Mechanisms by which IFN- coordinates this transition include aiding in the development of a Th1-type response (described earlier), directly promoting B cell isotype switching to IgG2a [54, 381, 382], and regulation of local leukocyteendothelial interactions (Table 1).”
Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells.
Macatonia, S. E., Hosken, N. A., Litton, M., Vieira, P., Hsieh, C. S., Culpepper, J. A., Wysocka, M., Trinchieri, G., Murphy, K. M., & O'Garra, A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5071 · Cited by 1,524
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
A new protein containing an SH2 domain that inhibits JAK kinases
Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., et al. (1997) · Nature · doi:10.1038/43213 · Cited by 1,408
Miura, M. (1993) · Cell · doi:10.1016/0092-8674(93)90486-a · Cited by 1,373
The Molecular Cell Biology of Interferon-gamma and its Receptor
Farrar, M. A., & Schreiber, R. D. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.003035 · Cited by 1,341 · cited 2×
“Mutant receptors with deletion or substitution of this sequence cannot internalize ligand, although signal transduction is not affected [42, 45].”
Altered immune responses in mice lacking inducible nitric oxide synthase
Wei, X.-Q., Charles, I. G., Smith, A., Ure, J., Feng, G.-J., Huang, F.-P., Xu, D., Mullers, W., Moncada, S., & Liew, F. Y. (1995) · Nature · doi:10.1038/375408a0 · Cited by 1,292
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene
Shimoda, K., van Deursent, J., Sangster, M. Y., Sarawar, S. R., Carson, R. T., Tripp, R. A., Chu, C., Quelle, F. W., Nosaka, T., Vignali, D. A. A., et al. (1996) · Nature · doi:10.1038/380630a0 · Cited by 1,278 · cited 1×
“[106, 151, 200–205].”
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,242 · cited 2×
“This is supported by the Stat1 KO mouse, which displays loss of only IFN signaling, despite multiple reports of Stat1 activation in response to a range of other cytokines in vitro [106, 151].”
Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice
Kaplan, M. H., Sun, Y.-L., Hoey, T., & Grusby, M. J. (1996) · Nature · doi:10.1038/382174a0 · Cited by 1,240 · cited 1×
“[106, 151, 200–205].”
A Mutation in the Interferon-γ –Receptor Gene and Susceptibility to Mycobacterial Infection
Newport, M. J., Huxley, C. M., Huston, S., Hawrylowicz, C. M., Oostra, B. A., Williamson, R., & Levin, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352602 · Cited by 1,199
Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells
Thierfelder, W. E., van Deursen, J. M., Yamamoto, K., Tripp, R. A., Sarawar, S. R., Carson, R. T., Sangster, M. Y., Vignali, D. A. A., Doherty, P. C., Grosveld, G. C., et al. (1996) · Nature · doi:10.1038/382171a0 · Cited by 1,180 · cited 1×
“[106, 151, 200–205].”
Interferon-γ: the Major Mediator of Resistance Against Toxoplasma gondii
Suzuki, Y., Orellana, M. A., Schreiber, R. D., & Remington, J. S. (1988) · Science · doi:10.1126/science.3128869 · Cited by 1,173 · cited 1×
“However, these mice show deficiencies in natural resistance to bacterial, parasitic, and viral infections such as vaccinia virus, Theiler’s murine encephalomyelitis virus, Leishmania major, Toxoplasma gondii, Listeria monocytogenes, and several poorly virulent mycobacteria species [54–59].”
Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors
Parganas, E., Wang, D., Stravopodis, D., Topham, D. J., Marine, J.-C., Teglund, S., Vanin, E. F., Bodner, S., Colamonici, O. R., van Deursen, J. M., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81167-8 · Cited by 1,156 · cited 2×
“Other than suppression of IFNsignaling, the cytokine response deficit of Jak2 KO mice is largely nonoverlapping compared with Jak1 KO mice [197, 198].”
Exportin 1 (Crm1p) Is an Essential Nuclear Export Factor
Stade, K., Ford, C. S., Guthrie, C., & Weis, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80370-0 · Cited by 1,141 · cited 1×
“Stat1 dephosphorylation by a nuclear protein tyrosine phosphate (PTP) allows the release of DNA and subsequent recognition of the NES by chromosome region maintenance/exportin 1 (CRM1), an export receptor for NES-containing proteins [190, 191].”
Stat5a is mandatory for adult mammary gland development and lactogenesis.
Liu, X., Robinson, G. W., Wagner, K. U., Garrett, L., Wynshaw-Boris, A., & Hennighausen, L. (1997) · Genes & Development · doi:10.1101/gad.11.2.179 · Cited by 1,111 · cited 1×
“[106, 151, 200–205].”
Kawai, T., Takeuchi, O., Fujita, T., Inoue, J.-I., Mühlradt, P. F., Sato, S., Hoshino, K., & Akira, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5887 · Cited by 1,095
Exacerbations of multiple sclerosis in patients treated with gamma interferon
Panitch, H., Haley, A., Hirsch, R., & Johnson, K. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92863-7 · Cited by 1,071 · cited 1×
“systemic lupus erythematosus [79, 80], multiple sclerosis [81],”
THE IFNγ RECEPTOR:A Paradigm for Cytokine Receptor Signaling
Bach, E. A., Aguet, M., & Schreiber, R. D. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.563 · Cited by 1,034 · cited 5×
“The IFNGR2 chain is generally the limiting factor in IFNresponsiveness, as the IFNGR1 chain is usually in surplus [8, 35].”
InfluentialMeurs, E., Chong, K., Galabru, J., Thomas, N. S. B., Kerr, I. M., Williams, B. R. G., & Hovanessian, A. G. (1990) · Cell · doi:10.1016/0092-8674(90)90374-n · Cited by 1,017 · cited 3×
“inhibiting viral and cellular protein synthesis [242].”
InfluentialInterferons: cell signalling, immune modulation, antiviral response and virus countermeasures
Goodbourn, S., Didcock, L., & Randall, R. E. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-10-2341 · Cited by 977
Sen, G. C. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.255 · Cited by 968 · cited 2×
“IFNsecretion by NK cells and possibly professional APCs is likely to be important in early host defense against infection, whereas T lymphocytes become the major source of IFN- in the adaptive immune response [12, 17].”
Jak2 Deficiency Defines an EssentialDevelopmental Checkpoint in DefinitiveHematopoiesis
Neubauer, H., Cumano, A., Müller, M., Wu, H., Huffstadt, U., & Pfeffer, K. (1998) · Cell · doi:10.1016/s0092-8674(00)81168-x · Cited by 914
The roles of IFNγ in protection against tumor development and cancer immunoediting
Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00038-7 · Cited by 899 · cited 1×
“[88, 89]).”
Interferon-γ –Receptor Deficiency in an Infant with Fatal Bacille Calmette–Guérin Infection
Jouanguy, E., Altare, F., Lamhamedi, S., Revy, P., Emile, J.-F., Newport, M., Levin, M., Blanche, S., Seboun, E., Fischer, A., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352604 · Cited by 895 · cited 1×
“in childhood [63–71].”
Serine phosphorylation of STATs
Decker, T., & Kovarik, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203481 · Cited by 887
Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon
Aggarwal, B. B., Eessalu, T. E., & Hass, P. E. (1985) · Nature · doi:10.1038/318665a0 · Cited by 884
Carnaud, C., Lee, D., Donnars, O., Park, S.-H., Beavis, A., Koezuka, Y., & Bendelac, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.4647 · Cited by 854 · cited 1×
“IFN- orchestrates leukocyte attraction and directs growth, maturation, and differentiation of many cell types [2–4], in addition to enhancing natural killer (NK) cell activity [5] and regulating B cell functions such as immunoglobulin (Ig) production and class switching [4, 6].”
Pfefferkorn, E. R. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.3.908 · Cited by 854
Rodig, S. J., Meraz, M. A., White, J. M., Lampe, P. A., Riley, J. K., Arthur, C. D., King, K. L., Sheehan, K. C. F., Yin, L., Pennica, D., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81166-6 · Cited by 853 · cited 1×
“, IL-6, IL-11, leukemia inhibitory factor receptors) [196].”
Requirement for Transcription Factor IRF-1 in NO Synthase Induction in Macrophages
Kamijo, R., Harada, H., Matsuyama, T., Bosland, M., Gerecitano, J., Shapiro, D., Le, J., Koh, S. I., Kimura, T., Green, S. J., et al. (1994) · Science · doi:10.1126/science.7510419 · Cited by 844
Reciprocal regulation of polarized cytokine production by effector B and T cells
Harris, D. P., Haynes, L., Sayles, P. C., Duso, D. K., Eaton, S. M., Lepak, N. M., Johnson, L. L., Swain, S. L., & Lund, F. E. (2000) · Nature Immunology · doi:10.1038/82717 · Cited by 839 · cited 1×
“[5, 12–16]).”
Gajewski, T. F., & Fitch, F. W. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.12.4245 · Cited by 834
A Mechanism for the Specific Immunogenicity of Heat Shock Protein-Chaperoned Peptides
Suto, R., & Srivastava, P. K. (1995) · Science · doi:10.1126/science.7545313 · Cited by 823
IL-18: A TH1 -inducing, proinflammatory cytokine and new member of the IL-1 family
Dinarello, C. A. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70518-x · Cited by 819 · cited 2×
“In macrophages, NK and T cells, the combination of IL-12 and IL-18 stimulation further increases IFNproduction [20, 23, 24, 27, 28].”
Inhibition of Viral Replication by Interferon-γ-Induced Nitric Oxide Synthase
Karupiah, G., Xie, Q.-W., Buller, R. M. L., Nathan, C., Duarte, C., & MacMicking, J. D. (1993) · Science · doi:10.1126/science.7690156 · Cited by 816
Shuai, K., Horvath, C. M., Huang, L. H. T., Qureshi, S. A., Cowburn, D., & Darnell, J. E. (1994) · Cell · doi:10.1016/0092-8674(94)90357-3 · Cited by 807 · cited 1×
“All Stat proteins possess a SH2 domain that when tyrosine phosphorylated, mediates homodimerization or heterodimerization with other Stat molecules [114, 115].”
Assembly, Transport, and Function of MHC Class II Molecules
Cresswell, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.259 · Cited by 807 · cited 2×
“[237–239]”
TLR4, but not TLR2, mediates IFN-β–induced STAT1α/β-dependent gene expression in macrophages
Toshchakov, V., Jones, B. W., Perera, P.-Y., Thomas, K., Cody, M. J., Zhang, S., Williams, B. R. G., Major, J., Hamilton, T. A., Fenton, M. J., et al. (2002) · Nature Immunology · doi:10.1038/ni774 · Cited by 803
A Single Phosphotyrosine Residue of Stat91 Required for Gene Activation by Interferon-γ
Shuai, K., Stark, G. R., Kerr, L. M., & Darnell, J. E. (1993) · Science · doi:10.1126/science.7690989 · Cited by 802 · cited 1×
“All Stat proteins possess a SH2 domain that when tyrosine phosphorylated, mediates homodimerization or heterodimerization with other Stat molecules [114, 115].”
Endotoxin signal transduction in macrophages
Sweet, M. J., & Hume, D. A. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.60.1.8 · Cited by 793
Self-citationYoshimoto, T., Takeda, K., Tanaka, T., Ohkusu, K., Kashiwamura, S., Okamura, H., Akira, S., & Nakanishi, K. (1998) · PubMed · Cited by 770
Alexander, W. S., Starr, R., Fenner, J. E., Scott, C. L., Handman, E., Sprigg, N. S., Corbin, J. E., Cornish, A. L., Darwiche, R., Owczarek, C. M., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80047-1 · Cited by 762 · cited 1×
“Conversely, SOCS-1 / mice are hyper-responsive to microbial infection, exhibit enhanced macrophage cytocidal activity, and die of IFN- -dependent, multisystem inflammatory tissue destruction in the absence of infection [180, 181].”
Self-citationThe protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction
Müller, M., Briscoe, J., Laxton, C., Guschin, D., Ziemiecki, A., Silvennoinen, O., Harpur, A. G., Barbieri, G., Witthuhn, B. A., Schindler, C., et al. (1993) · Nature · doi:10.1038/366129a0 · Cited by 760
Taub, D. D., Lloyd, A. R., Conlon, K., Wang, J. M., Ortaldo, J. R., Harada, A., Matsushima, K., Kelvin, D. J., & Oppenheim, J. J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1809 · Cited by 752
Preferential Migration of Activated CD4 + and CD8 + T Cells in Response to MIP-1α and MIP-1β
Taub, D. D., Conlon, K., Lloyd, A. R., Oppenheim, J. J., & Kelvin, D. J. (1993) · Science · doi:10.1126/science.7682337 · Cited by 730 · cited 1×
“[301] [155] Regulated on activation, normal T expressed and secreted (RANTES; CCL5) Chemoattractant for memory CD4 T cells and monocyte/macrophages.”
IFN- gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses.
Finkelman, F. D., Katona, I. M., Mosmann, T. R., & Coffman, R. L. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.4.1022 · Cited by 723 · cited 1×
“IFN- orchestrates leukocyte attraction and directs growth, maturation, and differentiation of many cell types [2–4], in addition to enhancing natural killer (NK) cell activity [5] and regulating B cell functions such as immunoglobulin (Ig) production and class switching [4, 6].”
Crystal Structure of a Tyrosine Phosphorylated STAT-1 Dimer Bound to DNA
Chen, X., Vinkemeier, U., Zhao, Y., Jeruzalmi, D., Darnell, J. E., & Kuriyan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81443-9 · Cited by 720 · cited 1×
“The crystal structure for tyrosine phosphorylated Stat1 bound to DNA has been determined [109].”
Yasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A., Wakioka, T., Ohtsuka, S., Imaizumi, T., Matsuda, T., Ihle, J. N., et al. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1309 · Cited by 719
Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters
Trowsdale, J., Hanson, I., Mockridge, I., Beck, S., Townsendt, A., & Kelly, A. (1990) · Nature · doi:10.1038/348741a0 · Cited by 704 · cited 1×
“Genes encoding the TAP subunits are located within the class II MHC locus and are coordinately expressed with MHC class I [220, 221].”
Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity
Ayer, D. E., Kretzner, L., & Eisenman, R. N. (1993) · Cell · doi:10.1016/0092-8674(93)90661-9 · Cited by 703 · cited 2×
“The level of active myc is negatively regulated by mad1, which sequesters the max coactivator away from myc and suppresses transcription of myc-inducible genes [259].”
Heufler, C., Koch, F., Stanzl, U., Topar, G., Wysocka, M., Trinchieri, G., Enk, A., Steinman, R. M., Romani, N., & Schuler, G. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260323 · Cited by 700
Chin, Y. E., Kitagawa, M., Su, W.-C. S., You, Z.-H., Iwamoto, Y., & Fu, X.-Y. (1996) · Science · doi:10.1126/science.272.5262.719 · Cited by 696
Maggi, E., Parronchi, P., Manetti, R., Simonelli, C., Piccinni, M. P., Rugiu, F. S., De Carli, M., Ricci, M., & Romagnani, S. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.7.2142 · Cited by 684 · cited 1×
“Conversely, IFN- exposure to CD4 Th2 populations displaying high levels of IFNGR2 inhibits proliferation and may induce the apoptotic program [35, 38, 39].”
Yoshimoto, T., Takeda, K., Tanaka, T., Ohkusu, K., Kashiwamura, S.-I., Okamura, H., Akira, S., & Nakanishi, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3400 · Cited by 675 · cited 1×
“[5, 12–16]).”
Interferons α and β as Immune Regulators—A New Look
Biron, C. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00154-6 · Cited by 667
Dighe, A. S., Richards, E., Old, L. J., & Schreiber, R. D. (1994) · Immunity · doi:10.1016/1074-7613(94)90087-6 · Cited by 663 · cited 1×
“display compromised tumor rejection [85–87].”
RANTES: a versatile and controversial chemokine
Appay, V., & Rowland-Jones, S. L. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(00)01812-3 · Cited by 650 · cited 1×
“[155, 302]”
Zhang, J.-G., Farley, A., Nicholson, S. E., Willson, T. A., Zugaro, L. M., Simpson, R. J., Moritz, R. L., Cary, D., Richardson, R., Hausmann, G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2071 · Cited by 627 · cited 1×
“SOCS-1 may also promote degradation of signaling machinery by binding to and targeting signaling molecules for the ubiquitin-proteasome pathway [178].”
Lorsbach, R. B., Murphy, W. J., Lowenstein, C. J., Snyder, S. H., & Russell, S. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53940-5 · Cited by 619
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500168 · Cited by 616
ANTIGEN PROCESSING AND PRESENTATION BY THE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX
York, I. A., & Rock, K. L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.369 · Cited by 610
Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis
Los, M., Craen, M. V. D., Penning, L. C., Schenk, H., Westendorp, M., Baeuerle, P. A., Dröge, W., Krammer, P. H., Fiers, W., & Schulze-Osthoff, K. (1995) · Nature · doi:10.1038/375081a0 · Cited by 607
Munder, M., Mallo, M., Eichmann, K., & Modolell, M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2103 · Cited by 600 · cited 2×
“These cytokines serve as a bridge to link infection with IFN- production in the innate-immune response [18–24].”
Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis
Jacob, C. O., & McDevitt, H. O. (1988) · Nature · doi:10.1038/331356a0 · Cited by 596
Deiss, L. P., Feinstein, E., Berissi, H., Cohen, O., & Kimchi, A. (1995) · Genes & Development · doi:10.1101/gad.9.1.15 · Cited by 592 · cited 1×
“[273–276]”
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4652 · Cited by 584
Shultz, L. D., Schweitzer, P. A., Rajan, T. V., Yi, T., Ihle, J. N., Matthews, R. J., Thomas, M. L., & Beier, D. R. (1993) · Cell · doi:10.1016/0092-8674(93)90369-2 · Cited by 581 · cited 1×
“Shp1 KO mice (motheaten mice, me/ me) die from a condition caused by dysregulation of a large number of cytokines, possibly including IFN- [188].”
New insights into the regulation of inducible nitric oxide synthesis
Morris, S. M., & Billiar, T. R. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.6.e829 · Cited by 576
Requirement of Serine Phosphorylation for Formation of STAT-Promoter Complexes
Zhang, X., Blenis, J., Li, H.-C., Schindler, C., & Chen-Kiang, S. (1995) · Science · doi:10.1126/science.7701321 · Cited by 573 · cited 2×
“The C-terminal transactivation domain contains the Y701 phosphorylation site and also a S727 phosphorylation site, both of which are functionally important for efficient signaling [110–113].”
Reduced Biopterin as a Cofactor in the Generation of Nitrogen Oxides by Murine Macrophages
Kwon, N. S., Nathan, C. F., & Stuehr, D. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47089-0 · Cited by 570
Kumar, A., Haque, J., Lacoste, J., Hiscott, J., & Williams, B. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6288 · Cited by 568
Toll receptors, CD14, and macrophage activation and deactivation by LPS
Dobrovolskaia, M. A., & Vogel, S. N. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01613-1 · Cited by 564
Caspases and caspase inhibitors
Villa, P., Kaufmann, S. H., & Earnshaw, W. C. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01107-9 · Cited by 563 · cited 2×
“[267–269]”
Interferon regulatory factors: the next generation
Mamane, Y., Heylbroeck, C., Génin, P., Algarté, M., Servant, M. J., LePage, C., DeLuca, C., Kwon, H., Lin, R., & Hiscott, J. (1999) · Gene · doi:10.1016/s0378-1119(99)00262-0 · Cited by 562 · cited 1×
“IRF-1 transcriptional regulatory activity is regulated independently in response to IFN- , virus, and dsRNA [161].”
Ledebur, H. C., & Parks, T. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.933 · Cited by 545
Buchmeier, N. A., & Schreiber, R. D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.21.7404 · Cited by 542 · cited 1×
“However, these mice show deficiencies in natural resistance to bacterial, parasitic, and viral infections such as vaccinia virus, Theiler’s murine encephalomyelitis virus, Leishmania major, Toxoplasma gondii, Listeria monocytogenes, and several poorly virulent mycobacteria species [54–59].”
Watling, D., Guschin, D., Müller, M., Silvennoinen, O., Witthuhn, B. A., Quelle, F. W., Rogers, N. C., Schindler, C., Stark, G. R., Ihle, J. N., et al. (1993) · Nature · doi:10.1038/366166a0 · Cited by 533 · cited 1×
“IFN signaling (Jak1) or IFN- signaling (Jak2) [194, 195].”
Activation of the STAT Signaling Pathway Can Cause Expression of Caspase 1 and Apoptosis
Chin, Y. E., Kitagawa, M., Kuida, K., Flavell, R. A., & Fu, X.-Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5328 · Cited by 521 · cited 1×
“Caspase 1 expression and resulting apoptosis can be IFN- -inducible [269] or can occur through IFN- -independent IRF-1 activity [267].”
Jonasch, E., & Haluska, F. G. (2001) · The Oncologist · doi:10.1634/theoncologist.6-1-34 · Cited by 518 · cited 1×
“Viral infection is the classic stimulus for IFN- and IFNexpression [8, 9].”
Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 Mutation
Dupuis, S., Dargemont, C., Fieschi, C., Thomassin, N., Rosenzweig, S., Harris, J., Holland, S. M., Schreiber, R. D., & Casanova, J.-L. (2001) · Science · doi:10.1126/science.1061154 · Cited by 517 · cited 1×
“A loss-of-function, heterozygous mutation in the Stat1 gene was recently described in humans, resulting in a dominantnegative effect over the WT allele for Stat1 activation [156].”
SOCS1 Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality
Marine, J.-C., Topham, D. J., McKay, C., Wang, D., Parganas, E., Stravopodis, D., Yoshimura, A., & Ihle, J. N. (1999) · Cell · doi:10.1016/s0092-8674(00)80048-3 · Cited by 516 · cited 1×
“Conversely, SOCS-1 / mice are hyper-responsive to microbial infection, exhibit enhanced macrophage cytocidal activity, and die of IFN- -dependent, multisystem inflammatory tissue destruction in the absence of infection [180, 181].”
Defective TNF-α-Induced Apoptosis in STAT1-Null Cells Due to Low Constitutive Levels of Caspases
Kumar, A., Commane, M., Flickinger, T. W., Horvath, C. M., & Stark, G. R. (1997) · Science · doi:10.1126/science.278.5343.1630 · Cited by 514 · cited 1×
“In the absence of IFN-induced tyrosine phosphorylation, Stat1 drives constitutive transcription of genes such as caspases [132, 133].”
Shiloh, M. U., MacMicking, J. D., Nicholson, S., Brause, J. E., Potter, S., Marino, M., Fang, F., Dinauer, M., & Nathan, C. (1999) · Immunity · doi:10.1016/s1074-7613(00)80004-7 · Cited by 508
Drapier, J., Wietzerbin, J., & Hibbs, J. B. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181018 · Cited by 497
Rollins, B. J., Yoshimura, T., Leonard, E. J., & Pober, J. S. (1990) · Europe PMC (PubMed Central) · Cited by 492
Jouanguy, E., Lamhamedi-Cherradi, S., Lammas, D., Dorman, S. E., Fondanèche, M.-C., Dupuis, S., Döffinger, R., Altare, F., Girdlestone, J., Emile, J.-F., et al. (1999) · Nature Genetics · doi:10.1038/7701 · Cited by 492 · cited 2×
“in childhood [63–71].”
Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., & Taniguchi, T. (1994) · Cell · doi:10.1016/0092-8674(94)90132-5 · Cited by 491
Differential Production of IL-12, IFN-α, and IFN-γ by Mouse Dendritic Cell Subsets
Hochrein, H., Shortman, K., Vremec, D., Scott, B., Hertzog, P., & O’Keeffe, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5448 · Cited by 490
Self-citationREGULATION OF MHC CLASS II GENES: Lessons from a Disease
Mach, B., Steimle, V., Martinez-Soria, E., & Reith, W. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.301 · Cited by 486 · cited 2×
“IFN- treatment further up-regulates class II MHC molecules in cells constitutively expressing class II MHC, such as B cells, DCs, and cells of the monocyte-macrophage lineage (professional APCs) [234].”
Taniguchi, T., & Takaoka, A. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00305-3 · Cited by 482
Xu, X., Sun, Y.-L., & Hoey, T. (1996) · Science · doi:10.1126/science.273.5276.794 · Cited by 480 · cited 1×
“In some promoters, transcription is maximal when more than one GAS-binding transcriptional activator binds to tandem GAS sites in the target gene promoter [130, 131].”
Caspases: key mediators of apoptosis
Thornberry, N. A. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90615-9 · Cited by 478
Interleukin-18 and Interleukin-1β: Two Cytokine Substrates for ICE (Caspase-1)
Fantuzzi, G., & Dinarello, C. A. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020506300324 · Cited by 466
Deiss, L. P., Galinka, H., Berissi, H., Cohen, O., & Kimchi, A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00760.x · Cited by 465 · cited 1×
“[277]”
Sarvetnick, N., Liggitt, D., Pitts, S. L., Hansen, S. E., & Stewart, T. A. (1988) · Cell · doi:10.1016/0092-8674(88)90414-x · Cited by 464 · cited 1×
“and insulin-dependent diabetes mellitus [82–84].”
IFN-γ production by antigen-presenting cells: mechanisms emerge
Frucht, D. M., Fukao, T., Bogdan, C., Schindler, H., O'Shea, J. J., & Koyasu, S. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02005-1 · Cited by 461 · cited 4×
“Many excellent reviews on the regulation of IFN- production have been published recently; the reader is referred to these for further information [11–13].”
InfluentialGreen, S. J., Crawford, R. M., Hockmeyer, J. T., Meltzer, M. S., & Nacy, C. A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4290 · Cited by 456
Greenlund, A. C., Farrar, M. A., Viviano, B. L., & Schreiber, R. D. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06422.x · Cited by 454 · cited 2×
“Residues (441)DKPH(444) are responsible for the binding specificity of IFNGR1 and Stat1 [41, 43, 44].”
GAS Elements: A Few Nucleotides with a Major Impact on Cytokine-Induced Gene Expression
DECKER, T., KOVARIK, P., & MEINKE, A. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.121 · Cited by 437 · cited 1×
“Stat1 homodimers bind DNA at GAS elements of consensus sequence TTCN(2-4)GAA [105].”
Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN- gamma .
Billiau, A., Heremans, H., Vandekerckhove, F., Dijkmans, R., Sobis, H., Meulepas, E., & Carton, H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.5.1506 · Cited by 435
Interferon-γ: Biology and Role in Pathogenesis
Billiau, A. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60428-9 · Cited by 433
Dorman, S. E., & Holland, S. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2901 · Cited by 429 · cited 1×
“in childhood [63–71].”
Three-dimensional structure of recombinant human interferon-gamma
Ealick, S., Cook, W., Vijay-Kumar, S., Carson, M., Nagabhushan, T., Trotta, P., & Bugg, C. (1991) · Science · doi:10.1126/science.1902591 · Cited by 426 · cited 1×
“Biologically active IFN- is a noncovalent homodimer formed by the self-association of two mature polypeptides in an antiparallel orientation [94, 95] and thus binds IFNGR1 in 2:2 binding stoichiometry [47, 95–97].”
Contribution of STAT SH2 Groups to Specific Interferon Signaling by the Jak-STAT pathway
Heim, M. H., Kerr, L. M., Stark, G. R., & Darnell, J. E. (1995) · Science · doi:10.1126/science.7871432 · Cited by 425 · cited 1×
“The activated Jak1 phosphorylates functionally critical tyrosines on residue 440 of each IFNGR1 chain to form two adjacent docking sites for the SH2 domains of latent Stat1 [41, 99–101].”
Tanaka, N., Kawakami, T., & Taniguchi, T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4531 · Cited by 423 · cited 1×
“IRF-1 drives inducible expression of many target genes through interaction with the IRF-E site, consensus G(A)AAA /C /CGAAA /C /C [102, 164].”
Bromberg, J. F., Horvath, C. M., Wen, Z., Schreiber, R. D., & Darnell, J. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7673 · Cited by 422 · cited 1×
“Although IFN- treatment of lymphocytes and fibroblasts inhibited cell growth, the same treatment in Stat1 / cells promoted proliferation and decreased apoptotic signals [133, 153, 154].”
Ohmori, Y., Schreiber, R. D., & Hamilton, T. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14899 · Cited by 413
DAP kinase links the control of apoptosis to metastasis
Inbal, B., Cohen, O., Polak-Charcon, S., Kopolovic, J., Vadai, E., Eisenbach, L., & Kimchi, A. (1997) · Nature · doi:10.1038/36599 · Cited by 395 · cited 1×
“[273–276]”
Song, M. M., & Shuai, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35056 · Cited by 395 · cited 1×
“Another SOCS protein, SOCS-3, is also induced by IFN- and negatively regulates IFN- signaling, although perhaps less effectively than SOCS-1 [182].”
Baek, K. J., Thiel, B. A., Lucas, S., & Stuehr, D. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36901-7 · Cited by 389 · cited 2×
“[285, 286]”
JNK2 and IKKβ Are Required for Activating the Innate Response to Viral Infection
Chu, W.-M., Ostertag, D., Li, Z.-W., Chang, L., Chen, Y., Hu, Y., Williams, B., Perrault, J., & Karin, M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80146-6 · Cited by 387
Denis, M. (1991) · Journal of Leukocyte Biology · doi:10.1002/jlb.49.4.380 · Cited by 384
Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells
Wallach, D., Fellous, M., & Revel, M. (1982) · Nature · doi:10.1038/299833a0 · Cited by 383 · cited 2×
“[4, 224–231]”
Goh, K. C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.20.5601 · Cited by 379 · cited 3×
“platelet-derived growth factor [110–112, 123, 124].”
Jouanguy, E., Lamhamedi-Cherradi, S., Altare, F., Fondanèche, M. C., Tuerlinckx, D., Blanche, S., Emile, J. F., Gaillard, J. L., Schreiber, R., Levin, M., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119810 · Cited by 377 · cited 2×
“in childhood [63–71].”
Role of interferon-gamma in immune cell regulation.
Young, H. A., & Hardy, K. J. (1995) · PubMed · Cited by 375
Human Mig chemokine: biochemical and functional characterization.
Liao, F., Rabin, R. L., Yannelli, J. R., Koniaris, L. G., Vanguri, P., & Farber, J. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1301 · Cited by 373 · cited 1×
“[155, 300] MIP-1 , MIP-1 (CCL3, CCL4) Chemoattractant for CD4 , CD8 , and memory T cells.”
The role of IL-18 in innate immunity
Akira, S. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00051-5 · Cited by 372 · cited 2×
“In macrophages, NK and T cells, the combination of IL-12 and IL-18 stimulation further increases IFNproduction [20, 23, 24, 27, 28].”
You, M., Yu, D.-H., & Feng, G.-S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2416 · Cited by 364 · cited 1×
“Shp2 null cells exhibit elevated tyrosine phosphorylation and DNA-binding ability of Stat1 and show enhanced suppression of cell growth with IFN- treatment [184].”
Zamanian-Daryoush, M., Mogensen, T. H., DiDonato, J. A., & Williams, B. R. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1278-1290.2000 · Cited by 361
Crystal structure of a complex between interferon-γ and its soluble high-affinity receptor
Walter, M. R., Windsor, W. T., Nagabhushan, T. L., Lundell, D. J., Lunn, C. A., Zauodny, P. J., & Narula, S. K. (1995) · Nature · doi:10.1038/376230a0 · Cited by 359 · cited 1×
“Biologically active IFN- is a noncovalent homodimer formed by the self-association of two mature polypeptides in an antiparallel orientation [94, 95] and thus binds IFNGR1 in 2:2 binding stoichiometry [47, 95–97].”
Sekimoto, T. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.7067 · Cited by 358 · cited 3×
“A model was proposed whereby Stat1 dimerization allows interaction with importin NPI-1, which then mediates translocation through the nuclear pore [135].”
Balachandran, S., Kim, C. N., Yeh, W.-C., Mak, T. W., Bhalla, K., & Barber, G. N. (1998) · The EMBO Journal · doi:10.1093/emboj/17.23.6888 · Cited by 355 · cited 1×
“implicated in numerous other functions, including activation of NF- B [243, 334], TNF- transcript splice regulation [244], induction of fas-mediated apoptosis [245, 246], and regulation of Stat1 activity [154, 247].”
Chan, E. D., & Riches, D. W. H. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.3.c441 · Cited by 353 · cited 1×
“Stat1 activation is necessary but not sufficient for transcription of a number of genes [125, 126].”
Kamijo, R., Le, J., Shapiro, D., Havell, E. A., Huang, S., Aguet, M., Bosland, M., & Vilcek, J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.4.1435 · Cited by 351 · cited 1×
“IFN- primes macrophages for more rapid and heightened responses to LPS [58, 388, 389] as well as other TLR agonists, such as unmethylated CpG motifs present in bacterial DNA (CpG DNA) [390].”
Chang, C.-H., Guerder, S., Hong, S.-C., van Ewijk, W., & Flavell, R. A. (1996) · Immunity · doi:10.1016/s1074-7613(00)80681-0 · Cited by 350
Chatterjee-Kishore, M., Wright, K. L., Ting, J. P.-Y., & Stark, G. R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.15.4111 · Cited by 346 · cited 2×
“Stat1 also constitutively regulates expression of the low molecular protein 2 (LMP2) gene [134].”
Biologic consequences of Stat1-independent IFN signaling
Gil, M. P., Bohn, E., O'Guin, A. K., Ramana, C. V., Levine, B., Stark, G. R., Virgin, H. W., & Schreiber, R. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111163898 · Cited by 344 · cited 3×
“[301] [155] Regulated on activation, normal T expressed and secreted (RANTES; CCL5) Chemoattractant for memory CD4 T cells and monocyte/macrophages.”
Second proteasome-related gene in the human MHC class II region
Kelly, A., Powis, S. H., Glynne, R., Radley, E., Beck, S., & Trowsdale, J. (1991) · Nature · doi:10.1038/353667a0 · Cited by 342 · cited 2×
“LMP-2 and LMP-7 map to class II MHC, and multicatalytic endopeptidase complex-like-1 (MECL-1) is encoded outside the MHC [210–216]”
David, M., Chen, H. E., Goelz, S., Larner, A. C., & Neel, B. G. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.7050 · Cited by 342
A role for the proteasome regulator PA28α in antigen presentation
Groettrup, M., Soza, A., Eggers, M., Kuehn, L., Dick, T. P., Schild, H., Rammensee, H.-G., Koszinowski, U. H., & Kloetzel, P.-M. (1996) · Nature · doi:10.1038/381166a0 · Cited by 337 · cited 2×
“It is thought to gear antigen processing toward more efficient generation of TAP- and class I MHC-compatible peptides to increase overall efficiency of class I MHC peptide delivery [217, 218].”
Complex roles of Stat1 in regulating gene expression
Ramana, C. V., Chatterjee-Kishore, M., Nguyen, H., & Stark, G. R. (2000) · Oncogene · doi:10.1038/sj.onc.1203525 · Cited by 336 · cited 1×
“[102–104]).”
Chang, C. H., Fontes, J. D., Peterlin, M., & Flavell, R. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1367 · Cited by 329
The Interferon-induced Double-Stranded RNA-Activated Protein Kinase Induces Apoptosis
Lee, S. B., & Esteban, M. (1994) · Virology · doi:10.1006/viro.1994.1151 · Cited by 321 · cited 1×
“[270–272]”
Eizirik, D. L., Flodström, M., Karlsen, A. E., & Welsh, N. (1996) · Diabetologia · doi:10.1007/bf00403906 · Cited by 319 · cited 1×
“[282–284]”
Cross Talk Between Interferon-γ and -α/β Signaling Components in Caveolar Membrane Domains
Takaoka, A., Mitani, Y., Suemori, H., Sato, M., Yokochi, T., Noguchi, S., Tanaka, N., & Taniguchi, T. (2000) · Science · doi:10.1126/science.288.5475.2357 · Cited by 319
Boes, B., Hengel, H., Ruppert, T., Multhaup, G., Koszinowski, U. H., & Kloetzel, P. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.901 · Cited by 319 · cited 1×
“[4, 217, 218, 219]”
Regulation of c-myc expression by IFN-γ through Stat1-dependent and -independent pathways
Ramana, C. V., Grammatikakis, N., Chernov, M., Nguyen, H., Chuan Goh, K., Williams, B. R. G., & Stark, G. R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.2.263 · Cited by 319 · cited 6×
“Expression of c-myc is induced rapidly by a number of growth factors and cytokines and is down-regulated by IFN- [154, 264].”
InfluentialHaspel, R. L., Salditt‐Georgieff, M., & Darnell, J. E. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01016.x · Cited by 312 · cited 1×
“This model is supported by work from other groups, demonstrating Stat1 tyrosine dephosphorylation in the nucleus and subsequent recycling of inactive Stat1 to the cytoplasm, and is consistent with the crystal structure of Stat1 bound to DNA [137, 189, 192, 193].”
Role of interferon-γ in immune cell regulation
Young, H. A., & Hardy, K. J. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.58.4.373 · Cited by 310 · cited 1×
“IFN- orchestrates leukocyte attraction and directs growth, maturation, and differentiation of many cell types [2–4], in addition to enhancing natural killer (NK) cell activity [5] and regulating B cell functions such as immunoglobulin (Ig) production and class switching [4, 6].”
Vinkemeier, U., Cohen, S. L., Moarefi, I., Chait, B. T., Kuriyan, J., & Darnell, J. E. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00946.x · Cited by 308 · cited 1×
“In some promoters, transcription is maximal when more than one GAS-binding transcriptional activator binds to tandem GAS sites in the target gene promoter [130, 131].”
Immune Defence in Mice Lacking Type I and/or Type II Interferon Receptors
VAN DEN BROEK, M. F., MULLER, U., HUANG, S., ZINKERNAGEL, R. M., & AGUET, M. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00090.x · Cited by 306 · cited 1×
“However, these mice show deficiencies in natural resistance to bacterial, parasitic, and viral infections such as vaccinia virus, Theiler’s murine encephalomyelitis virus, Leishmania major, Toxoplasma gondii, Listeria monocytogenes, and several poorly virulent mycobacteria species [54–59].”
Greenlund, A. C., Morales, M. O., Viviano, B. L., Yan, H., Krolewski, J., & Schreiber, R. D. (1995) · Immunity · doi:10.1016/1074-7613(95)90012-8 · Cited by 304 · cited 1×
“Phosphorylation induces dissociation of a Stat1 homodimer (also known as -IFN activation factor) from the receptor [100].”
Involvement of the IRF-1 Transcription Factor in Antiviral Responses to Interferons
Kimura, T., Nakayama, K., Penninger, J., Kitagawa, M., Harada, H., Matsuyama, T., Tanaka, N., Kamijo, R., Vilček, J., Mak, T. W., et al. (1994) · Science · doi:10.1126/science.8009222 · Cited by 304 · cited 1×
“IRF-1 functions are not limited to IFNsignaling; IFN- -independent activities in viral/bacterial infection, lymphocyte development, regulation of cell cycle, growth inhibition, apoptosis and tumor suppression have been reported [107, 123, 135, 159, 164–168].”
Gao, J., Morrison, D. C., Parmely, T. J., Russell, S. W., & Murphy, W. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.1226 · Cited by 303
Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor.
Tsujimoto, M., Yip, Y. K., & Vilček, J. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2441 · Cited by 301 · cited 1×
“Synergy may be also be a result of cross-talk between the IFN- and TNF- signaling pathways: TNF- stimulation is able to induce transcription of IRF-1 and promotes IFN- -induced Stat1 activation [405, 406]; IFN- induced PKR is able to signal to NF- B [407]; and IFNincreases surface expression of the TNF- receptor [280,…”
Harada, H., Takahashi, E., Itoh, S., Harada, K., Hori, T. A., & Taniguchi, T. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1500 · Cited by 299 · cited 1×
“IRF-2 also binds to the IRF-E site and largely functions to repress transcription of IRF-1-inducible genes through its transcriptional repressor domain [102, 159].”
A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.
Ayer, D. E., & Eisenman, R. N. (1993) · Genes & Development · doi:10.1101/gad.7.11.2110 · Cited by 291 · cited 1×
“In this way, the mad1-to-c-myc ratio determines whether a cell will proliferate (as a result of high levels of myc:max) or arrest in G1 (as a result of high levels of mad1:max) [259, 260].”
Bosisio, D., Polentarutti, N., Sironi, M., Bernasconi, S., Miyake, K., Webb, G. R., Martin, M. U., Mantovani, A., & Muzio, M. (2002) · Blood · doi:10.1182/blood.v99.9.3427 · Cited by 290
Interferon gamma receptor deficient mice are resistant to endotoxic shock.
Car, B. D., Eng, V. M., Schnyder, B., Ozmen, L., Huang, S., Gallay, P., Heumann, D., Aguet, M., & Ryffel, B. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1437 · Cited by 290
Interferon Tau: A Novel Pregnancy Recognition Signal
Bazer, F. W., Spencer, T. E., & Ott, T. L. (1997) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1997.tb00253.x · Cited by 287 · cited 1×
“Secretion of IFN- has only been reported in ruminants [10].”
Fujita, T., Reis, L. F., Watanabe, N., Kimura, Y., Taniguchi, T., & Vilcek, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9936 · Cited by 287
Grandori, C. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01025-6 · Cited by 285 · cited 1×
“In its active form, c-myc is associated with max, and the myc:max heterodimer activates transcription of genes required for cell cycle progression [265].”
Lack of Interferon γ Receptor β Chain and the Prevention of Interferon γ Signaling in T H 1 Cells
Pernis, A., Gupta, S., Gollob, K. J., Garfein, E., Coffman, R. L., Schindler, C., & Rothman, P. (1995) · Science · doi:10.1126/science.7618088 · Cited by 285 · cited 1×
“For example, some CD4 Th1 populations have very low levels of cell-surface expression of the IFNGR2 chain and thus low expression of active IFNGR, leading to a functional blockade of some aspects of IFN- signaling [36, 37].”
Xu, X., Fu, X.-Y., PLATE, J. M. D., & Chong, A. S. (1998) · PubMed · Cited by 283
Coordinated Dual Cleavages Induced by the Proteasome Regulator PA28 Lead to Dominant MHC Ligands
Dick, T. P., Ruppert, T., Groettrup, M., Kloetzel, P. M., Kuehn, L., Koszinowski, U. H., Stevanovic, S., Schild, H., & Rammensee, H.-G. (1996) · Cell · doi:10.1016/s0092-8674(00)80097-5 · Cited by 280 · cited 1×
“It is thought to gear antigen processing toward more efficient generation of TAP- and class I MHC-compatible peptides to increase overall efficiency of class I MHC peptide delivery [217, 218].”
Wolf, P. R., & Ploegh, H. L. (1995) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.11.110195.001411 · Cited by 278 · cited 2×
“[237–239]”
Kovarik, P., Stoiber, D., Eyers, P. A., Menghini, R., Neininger, A., Gaestel, M., Cohen, P., & Decker, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13956 · Cited by 273 · cited 2×
“For example, LPS signaling increases Stat1 S727 phosphorylation independently of Y701 phosphorylation in macrophages, thereby augmenting cellular responses to IFN- [110].”
Anderson, S. L., Carton, J. M., Lou, J., Xing, L., & Rubin, B. Y. (1999) · Virology · doi:10.1006/viro.1999.9614 · Cited by 272 · cited 1×
“[61, 249, 250]”
Interleukin‐12 production by human polymorphonuclear leukocytes
Cassatella, M. A., Meda, L., Gasperini, S., D'Andrea, A., Ma, X., & Trinchieri, G. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250102 · Cited by 269
Requirement for STAT1 in LPS-induced gene expression in macrophages
Ohmori, Y., & Hamilton, T. A. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.4.598 · Cited by 267
Class II transactivator regulates the expression of multiple genes involved in antigen presentation.
Chang, C. H., & Flavell, R. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.765 · Cited by 267 · cited 1×
“sins B, H, and L, lysosomal proteases implicated in production of antigenic peptides for class II MHC loading [240, 241]; and DM, a regulator of peptide accessibility to the peptide-binding cleft of class II MHC [235, 237].”
Green, S. J., Nacy, C. A., & Meltzer, M. S. (1991) · Journal of Leukocyte Biology · doi:10.1002/jlb.50.1.93 · Cited by 265
Sims, S. H., Cha, Y., Romine, M. F., Gao, P. Q., Gottlieb, K., & Deisseroth, A. B. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.690 · Cited by 262 · cited 1×
“Genes such as IRF-1, IP-10, ICAM-1, and iNOS contain Stat1 and NF- B-binding sites in their promoter, and maximal transcription requires both signals [158, 160, 402, 404, 418–423].”
Fellous, M., Nir, U., Wallach, D., Merlin, G., Rubinstein, M., & Revel, M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.10.3082 · Cited by 261 · cited 2×
“[4, 224–231]”
Ohmori, Y., & Hamilton, T. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5235 · Cited by 246
Interferon Action in Triply Deficient Mice Reveals the Existence of Alternative Antiviral Pathways
Zhou, A., Paranjape, J. M., Der, S. D., Williams, B. R. G., & Silverman, R. H. (1999) · Virology · doi:10.1006/viro.1999.9738 · Cited by 244
Reis, L. F., Harada, H., Wolchok, J. D., Taniguchi, T., & Vilcek, J. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05041.x · Cited by 243 · cited 2×
“[4, 224–231]”
Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation
Kovarik, P. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3660 · Cited by 243 · cited 3×
“LPS treatment following IFN- exposure increases the percentage of molecules phosphorylated on Y701 and S727 and subsequent Stat1 DNA-binding activity relative to IFN- treatment alone, thereby augmenting IFN- dependent, Stat1-mediated gene expression [123, 223].”
Stat1-independent regulation of gene expression in response to IFN-γ
Ramana, C. V., Gil, M. P., Han, Y., Ransohoff, R. M., Schreiber, R. D., & Stark, G. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111164198 · Cited by 243 · cited 2×
“Microarray analysis revealed that many genes, including the growth-promoting c-myc and c-jun genes, were induced in response to IFN- in Stat1 / cells [152].”
Mysterious liaisons: the relationship between c-Myc and the cell cycle
Obaya, A. J., Mateyak, M. K., & Sedivy, J. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202749 · Cited by 242 · cited 1×
“[263] [264] [154] [251] [265] [259]”
Synergistic Effects of IL-4 and IL-18 on IL-12-Dependent IFN-γ Production by Dendritic Cells
Fukao, T., Matsuda, S., & Koyasu, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.64 · Cited by 239 · cited 2×
“Negative regulators of IFN- production include IL-4, IL10, transforming growth factor- , and glucocorticoids [17, 21, 27–29].”
Kimura, T., Kadokawa, Y., Harada, H., Matsumoto, M., Sato, M., Kashiwazaki, Y., Tarutani, M., Sok‐Pin Tan, R., Takasugi, T., Matsuyama, T., et al. (1996) · Genes to Cells · doi:10.1046/j.1365-2443.1996.08008.x · Cited by 234 · cited 1×
“fend against a broad spectrum of pathogens [60, 61].”
Research works printed but not linked: 1
- Dey, 1999, Gamma interferon induces expression of Mad1 gene in macrophage, which inhibits colony-stimulating factor-1-dependent mitogenesis, J. Cell. Biochem., 72, 232, 10.1002/(sici)1097-4644(19990201)72:2<232::aid-jcb7>3.0.co;2-0 · DOI
Cited by
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Interferon-stimulated genes: A complex web of host defenses
Schneider, W. M., Chevillotte, M. D., & Rice, C. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120231 · Cited by 3,067
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Wang, W., Green, M., Choi, J. E., Gijón, M., Kennedy, P. D., Johnson, J. K., Liao, P., Lang, X., Kryczek, I., Sell, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1170-y · Cited by 2,880
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Garcia-Diaz, A., Shin, D. S., Moreno, B. H., Saco, J., Escuin-Ordinas, H., Rodriguez, G. A., Zaretsky, J. M., Sun, L., Hugo, W., Wang, X., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.031 · Cited by 1,942
“The activated dimers then accumulate in the nucleus to act as transcription factors (Schroder et al., 2004; Aaronson and Horvath, 2002).”
Role of cytokines in intervertebral disc degeneration: pain and disc content
Risbud, M. V., & Shapiro, I. M. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.160 · Cited by 1,767
Metadata
- Authors
- Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A.
- Affiliations
- The University of Queensland (AU)
- Monash Medical Centre (AU)
- Corresponding author
- Hume, David A
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-10-02
- Volume
- 75
- Issue
- 2
- Pages
- 163-189
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2167017590
- Cited by
- 4,120
- References
- 443
- Citations by year
- 2026: 141 · 2025: 166 · 2024: 208 · 2023: 231 · 2022: 229 · 2021: 252 · 2020: 243 · 2019: 213 · 2018: 193 · 2017: 225 · 2016: 236 · 2015: 246 · 2014: 209 · 2013: 224 · 2012: 195
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Leukocyte Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- interferon-gamma, IFN-gamma receptor, signal transduction, macrophage response, transcriptional regulation, antigen processing and presentation, antiviral state, apoptosis, immunomodulation, leukocyte migration, cytokine signaling, pathogen-associated molecular patterns
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Inflammation, Interferon-gamma, Macrophages, Signal Transduction, Receptor Cross-Talk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.